Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis
about
Post-Genomics and Vaccine Improvement for LeishmaniaIL-22 Protects against Tissue Damage during Cutaneous LeishmaniasisThe Combined Deficiency of Immunoproteasome Subunits Affects Both the Magnitude and Quality of Pathogen- and Genetic Vaccination-Induced CD8+ T Cell Responses to the Human Protozoan Parasite Trypanosoma cruziRegulation of immunity during visceral Leishmania infectionA Listeria monocytogenes-based vaccine that secretes sand fly salivary protein LJM11 confers long-term protection against vector-transmitted Leishmania major.Global distribution maps of the leishmaniasesGenomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathologyThe immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis.Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.Intermediate monocytes contribute to pathologic immune response in Leishmania braziliensis infections.Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infectionExposure to Leishmania braziliensis triggers neutrophil activation and apoptosis.Matrix metalloproteinase 9 production by monocytes is enhanced by TNF and participates in the pathology of human cutaneous Leishmaniasis.Prediction of CD8+ Epitopes in Leishmania braziliensis Proteins Using EPIBOT: In Silico Search and In Vivo Validation.Quantification of Leishmania (Viannia) Kinetoplast DNA in Ulcers of Cutaneous Leishmaniasis Reveals Inter-site and Inter-sampling Variability in Parasite LoadT-cell receptor Vβ repertoire of CD8+ T-lymphocyte subpopulations in cutaneous leishmaniasis patients from the state of Rio de Janeiro, Brazil.Lymphocytic Choriomeningitis Virus Expands a Population of NKG2D+CD8+ T Cells That Exacerbates Disease in Mice Coinfected with Leishmania major.Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion.Role of TEFFECTOR/MEMORY Cells, TBX21 Gene Expression and T-Cell Homing Receptor on Type 1 Reaction in Borderline Lepromatous Leprosy Patients.Blood Transcriptional Profiling Reveals Immunological Signatures of Distinct States of Infection of Humans with Leishmania infantum.CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production.Cutaneous Infection with Leishmania major Mediates Heterologous Protection against Visceral Infection with Leishmania infantumA Potential Role for Mononuclear Phagocytes in Cutaneous Ulcer Development in Human Immunodeficiency Virus-Leishmania braziliensis Coinfection.DETC-based bacterial cellulose bio-curatives for topical treatment of cutaneous leishmaniasis.Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species.Characterization of the Histopathologic Features in Patients in the Early and Late Phases of Cutaneous Leishmaniasis.The Role of CD4 and CD8 T Cells in Human Cutaneous Leishmaniasis.CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly.MDA5 Is Critical to Host Defense during Infection with Murine Coronavirus.Memory T cells in cutaneous leishmaniasis.Phenotypic and functional characteristics of HLA-DR+ neutrophils in Brazilians with cutaneous leishmaniasis.Leishmania major Infection-Induced VEGF-A/VEGFR-2 Signaling Promotes Lymphangiogenesis That Controls Disease.Cutaneous Leishmaniasis Induces a Transmissible Dysbiotic Skin Microbiota that Promotes Skin Inflammation.Immunologic Markers of Protection in Leishmania (Viannia) braziliensis Infection: A 5-Year Cohort StudyCytotoxic cell involvement in human cutaneous leishmaniasis: assessments in active disease, under therapy and after clinical cure.Potential Use of Interleukin-10 Blockade as a Therapeutic Strategy in Human Cutaneous Leishmaniasis.In Vitro Immunomodulatory Activity of a Transition-State Analog Inhibitor of Human Purine Nucleoside Phosphorylase in Cutaneous Leishmaniasis.Proteome profiling of human cutaneous leishmaniasis lesion.Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis.Cytotoxic activity in cutaneous leishmaniasis.
P2860
Q26752532-CF5DC00A-621A-4B8C-BB81-F7A39AD48122Q27301071-2203C3B8-C046-4DCB-A65C-D90DEF98E44FQ27314524-9DDF6702-EBB0-43DE-AF95-EDCD88871D33Q28066034-1BF42BD1-5B96-44DD-BE67-99F72F916B47Q33899733-3C50B49F-4B88-4F09-A4E6-22EDC2437F99Q33920731-BCE23BCB-21ED-441D-8F25-6787BC3751C6Q34717421-22C41B47-8C89-4175-AD95-2498B97388C9Q34871440-1AD8F40E-F43D-4970-B930-88D63B76E635Q34955529-9221FE12-DF9D-40AA-91EE-4A65AD2210BDQ35102707-7D3A9C3C-BDA4-43A6-B6BF-35E8D4D3A40BQ35105666-9AB0F74C-70EC-4176-9FE9-77CBCA62257AQ35163066-874D17EE-9FEA-4E60-8FB7-73BF3E32BD8BQ35418042-36FDB589-A241-45CE-BFAC-3763763BEDFCQ35532615-93FDE1AD-7B60-4247-B059-17E84659E76EQ35708519-DE042A4D-60ED-4C25-BC44-A0144A1A86D2Q36059663-CFB2FDC0-8B5B-4CA1-8047-9836A59BE88CQ36075248-F2D7D88C-3367-46CF-AC70-9F644161841AQ36133707-1B08DFAC-770D-4A08-A651-327C0CA0B6E8Q36169102-34D67AB1-8671-4F71-A943-F454F11AD9AFQ36187247-C95295F2-C9BE-4205-9753-D1B2724F57EDQ36278760-0454FF11-28BE-42D6-A6F3-287A988ED99BQ36331305-AE58DBC0-5070-4145-A7E4-3635C05915F7Q36359264-B34369C0-0845-4D98-AEA7-19CDF67FDDE5Q37475900-5BF01A2E-1867-42CD-BA89-29F3422431F9Q37671958-5EECCAA6-BCC6-4FCE-8485-788B5E663ACBQ37715361-E443C67A-D0A8-4C11-ADD9-CCBD9355D715Q38261036-70D3E058-2A54-4DF7-B91A-EDB5A0E5B660Q38387770-E57E4E10-B9B1-4344-812A-1CB7B3C6F99AQ38831191-EF61B137-29CC-4E35-B975-C3FC7D477099Q38919238-BEA48F69-D87D-4E36-9986-69D755167643Q39027191-A8B660AA-D5FD-4EF8-B00E-6730B56E5D04Q39543850-53747CB3-7980-4A94-8D62-7A9117778FCAQ40150240-0B8EA59A-08B9-4837-BCA7-5F29ABD807AEQ40670558-6672CD42-B089-4DDC-A0CE-C8B6990C75CEQ40772459-56ED3ACE-42D4-434D-A42D-8C23B457E207Q40939652-543BDE5B-7FB4-47CF-A6C2-F14CEB8B47FAQ41448585-D2B8B8D7-89B3-455A-A362-EDDB1F912920Q41744907-4518EC84-AD28-4279-8F77-ABDACFDD0D77Q46080853-CBC33FAF-D466-4E76-8A56-5AEBA097AE84Q46270906-160D23E7-20C7-410E-869A-817BBA03209A
P2860
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis
@ast
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis
@en
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis
@nl
type
label
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis
@ast
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis
@en
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis
@nl
prefLabel
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis
@ast
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis
@en
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis
@nl
P2093
P2860
P50
P3181
P1433
P1476
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis
@en
P2093
Daniel P Beiting
Fernanda O Novais
Gordon Ruthel
Joel W Graff
Lucas P Carvalho
Mary E Wilson
Michael R Betts
Phillip Scott
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1003504
P407
P577
2013-01-01T00:00:00Z